Taxpayers are funding expensive drug development, report says

Dutch News

10 May 2019 - The Dutch government invests tens of millions of euros every year in small biotech companies which are developing the expensive medicines ministers are trying to make cheaper, according to a new report. 

The government places no conditions on its loans and grants to biotech and pharma start-ups about the eventual prices they will charge for their drugs, the report, by multinational research groups Somo and Wemos said. 

‘Pharmaceutical companies argue that the reason their drugs are so expensive is because research and development is expensive, but this is simply not true,’ said Somo researcher Esther de Haan.

Read Dutch News article

Michael Wonder

Posted by:

Michael Wonder